9 research outputs found
Spanish version of the Oral Health Impact Profile (OHIP-Sp)
- Author
- AS McMillan
- AS McMillan
- BH de Oliveira
- C McGrath
- C Okunseri
- CA Ferreira
- CD Llewellyn
- CH Yu
- CM de Oliveira
- D Locker
- D Locker
- D Locker
- D Locker
- DE Beaton
- European Research Group on Health Outcomes
- F Guillemin
- G Heydecke
- GD Slade
- GD Slade
- GD Slade
- GD Slade
- GH Gilbert
- H Murray
- HL Broder
- I Needleman
- JA Hanley
- JG Steele
- JM Bland
- KK Soe
- L Ekanayake
- LJ Cronbach
- MCM Wong
- MT John
- MT John
- MT John
- MT John
- NM Nuttall
- NR Kressin
- P Allison
- P Larsson
- PF Allen
- PF Allen
- PF Allen
- PG Robinson
- R Lopez
- R Lopez
- R Lopez
- R Lopez
- R Lopez
- R Lopez
- R Saub
- Rodrigo Lopez
- RW Massof
- SKS Ng
- StataCorp.
- Vibeke Baelum
- WC Lee
- Publication venue
- BioMed Central
- Publication date
- 01/07/2006
- Field of study
BACKGROUND: The need for appraisal of oral health-related quality of life has been increasingly recognized over the last decades. The aims of this study were to develop a Spanish version (OHIP-Sp) of the Oral Health Impact Profile and to evaluate its convergent and discriminative validity, and its internal consistency. METHODS: The original 49-items OHIP was translated to Spanish, revised for understanding and semantics by two independent dentists, and then translated back to English by an independent bilingual dentist. The data originated in a cross sectional study conducted among high school students from the Province of Santiago, Chile. The study group was sampled using a multistage random cluster procedure yielding 9,203 students aged 12–21 years. All selected students were invited to participate and all filled a questionnaire with information on socio-demographic factors; oral health related behaviors; and self-reported oral health status (good, fair or poor). From this group, 9,163 students also accepted to fill a detailed questionnaire on socio-economic indicators and to receive a clinical examination comprising direct recordings of clinical attachment levels (CAL) in molars and incisors, tooth loss, and the presence of necrotizing ulcerative gingival lesions. RESULTS: The participation rate and the questionnaire completeness were high with OHIP-Sp total scores being computed for 9,133 subjects. Self-perceived oral health status was associated with the total OHIP-Sp score and all its domains (Spearman rank correlation). The OHIP-Sp total score was also directly associated with the 4 dental outcomes investigated (Mann-Whitney test) and the largest impact was found for the outcomes, 'tooth loss' with a mean OHIP-Sp score = 13.5 and 'CAL >= 3 mm' with a mean OHIP-Sp score = 13.0. CONCLUSION: The OHIP-Sp revealed suitable convergent and discriminative validity and appropriate internal consistency (Cronbach's α). Further studies on OHIP-Sp warrant the inclusion of populations with a higher disease burden; and the use of test-retest reliability exercises to evaluate the stability of the test
Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000
- Author
- Al Khaja
- Al Mahroos
- Ambrosioni
- Buring
- Chobanian
- Croog
- Cushman
- Dahlof
- Estacio
- Frattola
- Garg
- Glynn
- Hansson
- Hansson
- Joint National Committee on Detection Evaluation, and Treatment of High Blood Pressure
- Lacourciere
- Lebovitz
- Lewis
- Manolio
- Medical Research Council Working Party
- Medical Research Council Working Party
- Messerli
- Monane
- Multiple Risk Factor Intervention Trial Research Group
- Parati
- Pfeffer
- Psaty
- Ramsay
- Remuzzi
- Rotmensch
- Salvetti
- SHEP Cooperative Research Group
- Siegel
- Tatti
- The European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery (EUROPA) Disease Investigators
- The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators
- The National High Blood Pressure Education Programme Working Group
- Wing
- World Health Organization/International Society of Hypertension (WHO/ISH)
- Publication venue
- 'Wiley'
- Publication date
- 01/01/2006
- Field of study
Diabetes Mellitus
- Author
- Action to Control Cardiovascular Risk in Diabetes Study Group (ACCORD)
- ADA
- ADA and European Association for the Study of Diabetes
- American Diabetes Association (ADA)
- Andersen
- Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
- BARI 2D Study Group
- Brenner
- Brown
- Centers for Disease Control and Prevention (CDC)
- Colberg
- Colwell
- DeFronzo
- Diabetes Control and Complications (DCCT) Research Group
- Diabetes Control and Complications Trial (DCCT) Research Group
- Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group
- Diabetes Prevention Program Research Group
- Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group
- Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
- Foody
- Furnary
- Goldman
- Grundy
- Grundy
- Haffner
- Haire-Joshu
- Hanson
- Hayden
- Heart Outcomes Prevention Evaluation (HOPE) Study Investigators
- Heart Protection Study Collaborative Group
- Hollingsworth
- Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure (JNC)
- Kitzmiller
- Klein
- Klein
- Knowler
- Lewis
- Lewis
- Lindholm
- Mayfield
- Molitch
- National Cholesterol Education Program (NCEP) Expert Panel on Detection
- National Institutes of Health National Heart, Lung and Blood Institute, North American Association for the Study of Obesity 2000
- Nelson
- Nissen
- Ornoy
- Perreault
- Pilz
- Pyorala
- Reaven
- Reichard
- Remuzzi
- Renders
- Ridker
- Ruderman
- Scranton
- Shah
- Suarez
- Task Force on Community Preventive Services
- Tuomilehto
- UK Prospective Diabetes Study (UKPDS) Group
- UKPDS Group
- Umpierrez
- US Preventive Services Task Force (USPSTF)
- Vaccaro
- VADT 2009
- Van den Berghe
- Van den Berghe
- Vijan
- Wagner
- Publication venue
- 'Elsevier BV'
- Publication date
- 01/01/2011
- Field of study
Gender differences in the effects of cardiovascular drugs
- Author
- American College of Cardiology/American Heart Association Task Force on Practice Guidelines
- American Heart Association Statistics Committee and Stroke Statistics Subcommittee
- Antithrombotic Trialists' Collaboration
- APPROVE Investigators
- ARISTOTLE Committees and Investigators
- ASSENT-2 Investigators. Assessment of the Safety and Efficacy of a New Thrombolytic
- ATLAS ACS 2–TIMI 51 Investigators
- Authors/Task Force Members
- AVERROES Steering Committee and Investigators
- BEAUTIFUL Investigators
- Beta-Blockers in Heart Failure Collaborative Group
- Canadian Acute Coronary Syndrome Registry I and II Investigators
- Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group
- Carvedilol Prospective Randomized Cumulative Survival Study Group
- CHAMPION PHOENIX Investigators
- CHARM Investigators and Committees
- Cholesterol Treatment Trialists' (CTT) Collaboration
- Collaboration Antithrombotic Trialists
- CRUSADE Investigators
- ENGAGE AF-TIMI 48 Investigators
- Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
- ESPRIT Investigators
- ESSENCE (Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events) and TIMI (Thrombolysis in Myocardial Infarction) 11B Investigators
- EUGenMed Cardiovascular Clinical Study Group
- European Atherosclerosis Society Consensus Panel
- Fibrinolytic Therapy Trialists' (FTT) Collaborative Group
- Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators
- For the ACE inhibitor myocardial infarction collaborative group
- For the Amlodipine Cardiovascular Community Trial Study Group
- For the GUSTO-I Investigators
- For the HOT Study Group
- For the SWORD Investigators
- Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group
- Gruppo Italiano per lo Studio Della Streptochinasi nell'Infarto Miocardico (GISSI)
- Gusto V Investigators
- INITIATIVE Investigators
- Institute of Medicine (US) Committee on Women's Health Research Board on Population Health
- INTERHEART Study Investigators
- ISCOAT Study Group (Italian Study on Complications of Oral Anticoagulant Therapy)
- ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
- LIFE Study Group
- National Institutes of Health
- OASIS-6 Investigators
- OASIS-6 Trial Group
- Office of Extramural Research NIH
- OPTIMAAL Steering Committee of the OPTIMAAL Study Group
- PARADIGM-HF Committees Investigators
- PARADIGM-HF Investigators and Committees
- PLATO Investigators
- PLATO study group
- RE-LY Steering Committee and Investigators
- REMIT Investigators
- REPLACE-2 Investigators
- REPLACE-2 Investigators
- ROCKET AF Investigators
- SCAAR Study Group
- SHIFT Investigators
- SYNERGY Trial Investigators
- The GUSTO Investigators
- The Heart Outcomes Prevention Evaluation Study Investigators
- The MERIT-HF Study Group
- The SOLVD Investigattors
- TIMI 11A Investigators
- TRITON-TIMI 38 Investigators
- US General Accounting Office (GAO)
- VALIANT Investigators
- Valsartan Heart Failure Trial Investigators
- Valsartan in Acute Myocardial Infarction Trial Investigators
- VALUE Trial Group
- Women's Health Initiative Investigators
- Working Group on Thrombosis of the Italian Society of Cardiology
- Writing Group for the Women's Health Initiative Investigators
- Publication venue
- 'Oxford University Press (OUP)'
- Publication date
- Field of study
The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus
- Author
- A. D. Morris
- A. D. Struthers
- A. Dawson
- AC Dortimer
- AD Struthers
- BA Vakilli
- BH Lorell
- C Falcone
- D Hill
- D Levy
- D Levy
- EUROASPIRE I and II Group
- European Study Group on Diastolic Heart Failure
- G Schillaci
- G Schillaci
- G Simone de
- GM Reaven
- H King
- H Schirmer
- Heart Outcomes Prevention Evaluation (HOPE) Study Investigators
- HM Krumholz
- J Mathew
- JE Liu
- JE Møller
- JK Ghali
- JM Sullivan
- K Karason
- K Wachtell
- L Hall
- L Rytter
- M Diamant
- M Eren
- M Galderisi
- M Koren
- M Laakso
- M Lauer
- M Muiesan
- M Zabalgoitia
- MD Witham
- MJ Koren
- MR Tullio Di
- N Andersen
- NB Schiller
- P Gosse
- P Poirier
- P Verdecchia
- PM Okin
- R Devereux
- R Willenheimer
- RB Devereux
- RB Devereux
- S Woodfield
- T Kuroda
- TA McDonagh
- The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
- TY Goraya
- WB Kannel
- World Health Organization
- Y Liao
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- 01/10/2005
- Field of study
Inhibiting the renin-angiotensin system: Why and in which patients
- Author
- ACTIVE Steering Committee
- Acute Infarction Ramipril Efficacy Study Investigators
- Aksnes
- ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
- American Diabetes Association
- American Heart Association
- Antman
- Bakris
- Barnett
- Berra
- Brenner
- Burnier
- Carson
- Chobanian
- Cohen
- Cohn
- Cohn
- Dahlöf
- de Zeeuw
- Diener
- DREAM Trial Investigators
- Estacio
- EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
- Flather
- Givertz
- Glasser
- Granger
- Grassi
- Gress
- Hansson
- Heart Outcomes Prevention Evaluation Study Investigators
- Heart Outcomes Prevention Evaluation Study Investigators
- HOPE Study Investigators
- Hunt
- Jafar
- Kaschina
- Kilo
- Klag
- Lind
- Lindholm
- Linz
- Lithell
- Maggioni
- Malmqvist
- Manjunath
- McKelvie
- McMurray
- Mogensen
- Moser
- Nakao
- National Kidney Foundation
- Olsen
- ONTARGET Investigators
- ONTARGET/TRANSCEND Investigators
- Opie
- Padwal
- Parving
- Patel
- PEACE Trial Investigators
- Phillips
- Pierson
- Pitt
- Pitt
- Pohl
- Prospective Studies Collaboration
- Ruggenenti
- Schmieder
- Shafiq
- Shiuchi
- Sica
- Smith
- SOLVD Investigators
- Taal
- ThĂĽrmann
- Unger
- Verdecchia
- Viberti
- Weinberg
- World Health Organization
- Wright
- Zhou
- Publication venue
- 'Wiley'
- Publication date
- Field of study
Changes in blood pressure classification, blood pressure goals and pharmacological treatment of essential hypertension in medical guidelines from 2003 to 2013
- Author
- ADVANCE Collaborative Group
- Agodoa
- Anderson
- Aronow
- Bakris
- Bangalore
- Beckett
- Berl
- Black
- Blood Pressure Lowering Treatment Trialists' Collaboration
- Borghi
- Brenner
- Brown
- Canadian Hypertension Education Program (CHEP)
- Canadian Hypertension Education Program (CHEP)
- Chen
- Chobanian
- Cohn
- Cohn
- Collins
- Coope
- Cooper-DeHoff
- Cutler
- Dahlof
- Dahlof
- Dahlof
- Dickstein
- Diener
- Ducharme
- Elliott
- Estacio
- Estacio
- Franklin
- Freemantle
- Giugliano
- Gong
- Gradman
- Grossman
- Guidelines Committee
- Guidelines Committee
- Guidelines Committee
- Gustafsson
- Haller
- Hansson
- Hansson
- Hansson
- Hansson
- Heart Outcomes Prevention Evaluation (HOPE) Study investigators
- Jafar
- Jamerson
- JNC 6. National High Blood Pressure Education Program
- Julius
- Kampus
- Khan
- Kunz
- Law
- Lee
- Lewington
- Lewis
- Lewis
- Lindholm
- Lithell
- Liu
- MacMahon
- Maggioni
- Management of hypertension in aduts in primary care NICE/BHS
- Mancia
- Mann
- Mann
- Manolis
- Martin
- National Institute for Health and Clinical Excellence (NICE)
- NHS Evidence
- Nissen
- Packer
- Parving
- Pfeffer
- Pfeffer
- Pitt
- Pitt
- PROGRESS Collaborative Study Group
- Psaty
- Psaty
- Rosendorff
- Ruilope
- Schrader
- Schrier
- Schrier
- Shekelle
- SHEP Cooperative Research Group
- Staessen
- Telmisartan Randomized Assessment Study in ACE intolerant subjects with cardiovascular disease (TRANSCEND) Investigators
- Teo
- The ACCORD Study Group
- The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
- The PEACE trial investigators
- Udelson
- UK Prospective Diabetes Study Group
- Van Vark
- Verdecchia
- Wald
- Wang
- Williams
- Wing
- Wiyonge
- World Health Organization/International Society of Hypertension
- World Health Report 2002
- Wright
- Wright
- Yusuf
- Zanchetti
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society 2004 - BHS IV
- Author
- A Adler
- A Carlsson
- A Carter
- A Deary
- A Reinders
- A Siami
- A Zanchetti
- A Zanchetti
- A Zanchetti
- A Zanchetti
- AA Nabulsi
- AH Shennan
- AJ Dobson
- AJ Silman
- Anonymous
- Antithrombotic Trialists’ Collaboration
- Australian National Health and Medical Research Council Dietary Salt Study Management Committee
- Australian National Health and Medical Research Council Dietary Salt Study Management Committee
- AV Chobanian
- AV Chobanian
- B Arrol
- B Carlberg
- B Dahlöf
- B Williams
- B Williams
- B Williams
- B Williams
- B Williams
- B Williams
- BJ Materson
- BJ Materson
- BJ Wilson
- Blood Pressure Lowering Treatment Trialists’ Collaboration
- Blood Pressure Lowering Treatment Trialists’ Collaboration
- BM Brenner
- BM Sibai
- BM Sibai
- C Bulpitt
- C Lydakis
- C Nowson
- C Patel
- C Patel
- C Patel
- C Power
- C Silagy
- CDA Wolfe
- CE Mogensen
- CL Hart
- CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group
- CM Reid
- CM Viscoli
- CR Gibbs
- D Grobbee
- D Lane
- D Wood
- DA Lawlor
- DG Henderson
- DL Clement
- DQ Bao
- DW Johnston
- E Barrett-Connor
- E Barrett-Connor
- E O’Brien
- E O’Brien
- E O’Brien
- E O’Brien
- E O’Brien
- EJ Lewis
- EJ Lewis
- ESB Wilson
- European Atrial Fibrillation Trial Study Group
- EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators
- Expert Panel on Detection Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
- F Broughton Pipkin
- F Forette
- F Gueyffier
- FC Luft
- FC Luft
- FH Messerli
- FJ He
- FM Sacks
- FM Sacks
- FM Sacks
- FP Cappuccio
- G Chatellier
- G Dekker
- G Harper
- G Mancia
- G Navis
- GA Kelley
- GA Sagnella
- GCS Smith
- GL Bakris
- GL Bakris
- Gruppo Italiano di Studi Epidemiologici in Nefrologia
- GS Stergiou
- GT McInnes
- Guidelines Committee
- Guidelines Subcommittee
- H Lithell
- HB Rubins
- HC Gerstein
- HCS Wallenburg
- Heart Protection Study Collaborative Group
- Heart Protection Study Group
- HH Parving
- HH Parving
- HL Hillege
- HP Adams
- HS Jorgensen
- HU Irgens
- Hypertension Stroke Co-operative Study Group
- I Bidlingmeyer
- I Giatras
- I Kawachi
- I Kuwajima
- IB Puddey
- Imperial Cancer Research Fund OXCHECK Study Group
- IU Haq
- J Bosch
- J Chalmers
- J Cockburn
- J Hays
- J He
- J He
- J Leonardi-Bee
- J Mayet
- J Redon
- J Schrader
- J Shepherd
- J Shepherd
- J Stamler
- J Stamler
- J Tuomilehto
- J Tuomilehto
- JA Berlin
- JA Blomenthal
- JA Cutler
- JA Halbert
- JA Metz
- JA Staessen
- JA Staessen
- JA Staessen
- JCM Witteman
- JD Curb
- JD Neaton
- JD Swales
- JD Swales
- JE Dickerson
- JE Neter
- JG Douglas
- JH Laragh
- JL Tang
- JM Geleijnse
- JM Hagberg
- JM Lazarus
- JM Roberts
- JM Roberts
- JMM Evans
- JN Morris
- Joint National Committee on Prevention Detection, Evaluation, and Treatment of High Blood Pressure
- JP Midgley
- JR Crouse
- JR Downs
- JR Higgins
- JS Gill
- JS Jensen
- JT Wright
- K Wolf-Maier
- KG Lim
- KM Anderson
- L Butters
- L Duley
- L Hansson
- L Hansson
- L Hansson
- L Hansson
- L Hansson
- L Hooper
- L Lind
- L Lindholm
- L Niskanen
- L Rosenberg
- L Sandvik
- L Thijs
- LC Chappell
- LC Chappell
- LC Chesley
- LE Daly
- LE Griffith
- LE Ramsay
- LH Lindholm
- LH Lindholm
- LH Lindholm
- LJ Appel
- LM Ruilope
- LMH Wing
- LP Svetkey
- LP Svetkey
- LS Trupin
- M Britton
- M Eccles
- M Ezzati
- M Hansenns
- M Law
- M Ravid
- M Raw
- MA Gall
- ME Cooper
- MH Schein
- MJ Brown
- MJ Brown
- MJ Brown
- MJ Brown
- MJ Brown
- MJ Thun
- MS Dennis
- MZ Diaz
- N Kaplan
- N Nakao
- NB Shulman
- NF Gordon
- NJ Wald
- NR Poulter
- OK Andersson
- P Brindle
- P Omvik
- P Owens
- P Primatesta
- P Primatesta
- P Primatesta
- P Rubin
- P Sever
- P Sever
- P von Dadelszen
- PATS Collaborating Group
- PF Kokkinos
- PK Whelton
- PK Whelton
- PK Whelton
- PM Kyle
- PM McKeigue
- PM Rothwell
- PO Lim
- PR Conlin
- PROGRESS Collaborative Group
- Prospective Studies Collaboration
- PS Sever
- PS Sever
- PY Robillard
- R Bigazzi
- R Collins
- R Collins
- R Collins
- R Doll
- R Matheswaran
- RC Wimalasundera
- RJ Weir
- RM Conroy
- RO Estacio
- RO Estacio
- RP Naden
- RS Khattar
- RS Paffenberger
- RS Vasan
- RW Braith
- RW Schrier
- S Anderssen
- S Attwood
- S Caritis
- S Ebrahim
- S Eriksson
- S Hood
- S Hulley
- S Julius
- S Klahr
- S Lewington
- S MacMahon
- SA Yarows
- SE Gariballa
- SE Kjeldsen
- SH Jee
- SHEP Co-operative Research Group
- SJ Taler
- SM Haffner
- SP Whelton
- SS Franklin
- T Ekbom
- T Ohkubo
- T Ohkubo
- T Tsutamoto
- TA Lakka
- TC Beard
- TG Robinson
- TG Robinson
- TH Jafar
- TH Jafar
- The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
- The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
- The Dutch TIA Trial Study Group
- The Euclid Study Group
- The Heart Outcomes Prevention Evaluation Study Investigators
- The Heart Outcomes Prevention Evaluation Study Investigators
- The Heart Outcomes Prevention Evaluation Study Investigators
- The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
- The Magpie Trial Collaborative Group
- The Trials of Hypertension Prevention Collaborative Research Group
- The writing group for the PEPI trial
- TMM Farley
- TW Gress
- UKPDS Group
- United Kingdom Prospective Diabetes Study Group
- VG Athyros
- VJ Stevens
- W Dong
- WM Vollmer
- Working Party
- World Health Organization-International Society of Hypertension Writing Group
- Writing Group for the Women's Health Initiative Investigators
- X Xin
- Y Kawano
- Y Lacourciere
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- 01/01/2004
- Field of study
ANTICOAGULANTS, THROMBOLYTIC AGENTS, AND ANTI-PLATELET DRUGS
- Author
- A European Collaborative Study
- Abbott
- Abdel-Raheem
- Abuosa
- Adjiman
- Adler
- Adorati
- Ager
- Aggeler
- Aguirre
- Ahmad
- Ahmad
- Ahmed
- AIMS Trial Study Group
- Ainley
- Aithal
- Akle
- Akyol
- Al-Khadra
- Albers
- Albert
- Ali
- Ali
- Alonso-Martinez
- Alton
- Ambre
- Anagrelide Study Group
- Ancillo
- Anderson
- Anderson
- Angelides
- Annegers
- Anonymous
- Anonymous
- Anonymous
- Anonymous
- Anonymous
- Anonymous
- Ansell
- Antiplatelet Trialists’ Collaboration
- Antithrombotic Trialists’ Collaboration
- Antman
- Argent
- Arnold
- Ascah
- Aspirin Myocardial Infarction Study Research Group
- Aster
- Aster
- Aumègeat
- Awni
- Aylward
- Babaoglu
- Bachmann
- Bachmann
- Bachmann
- Baciewicz
- Baciewicz
- Baciewicz
- Badger
- Badger
- Baer
- Bagheri
- Baker
- Bal Dit Sollier
- Balato
- Balduini
- Barak
- Barbaro
- Barkley
- Barnes
- Baron
- Barrier
- Barrowcliffe
- Bartle
- Bates
- Bauer
- Bauer
- Bauer
- Bauer
- Baur
- Bebbington
- Bechtold
- Becker
- Becker
- Becker
- Been
- Belay
- Bell
- Bell
- Beller
- Beltran-Robles
- Bennett
- Bennett
- Bennett
- Bergsrud
- Beringer
- Berkowitz
- Berkun
- Berod
- Beyth
- Bianchine
- Bianco
- Bielen
- Bijlstra
- Biour
- Bircher
- Birgegard
- Biswas
- Bjoraker
- Blackwell
- Blankenship
- Blankenship
- Blankenship
- Blower
- Blum
- Blum
- Boeijinga
- Bonavina
- Boshkov
- Bosse
- Boston Collaborative Drug Surveillance Program Boston Universtiy Medical Center
- Bounameaux
- Bouros
- Bouros
- Bouros
- Bovill
- Bowler
- Brack
- Brandt
- Brandt
- Bransgrove
- Braun-Moscovici
- Braverman
- Brazier
- Bredberg
- Breddin
- Brener
- Brigot
- Broekmans
- Brooks
- Brouse
- Brown
- Brown
- Brown
- Bruning
- Bruns
- Brunskill
- Bruynzeel
- Bucknall
- Bullen
- Buller
- Buller
- Burgess
- Burton
- Byrne
- Cahill
- Cairns
- Calota
- Camara
- Campanelli
- Campbell
- Canova
- CAPRIE Steering Committee
- CAPRIE Steering Committee
- Caraco
- Cardenas
- Carlson
- Carlsson
- Carter
- Chan
- Chan
- Chan
- Chan
- Chan
- Chang
- Chatterjea
- Chau
- Chen
- Cheng
- Cheng
- Chesebro
- Chigot
- Chong
- Chong
- Christensen
- Christensen
- Chu
- Chung
- Cicale
- Ciccone
- Cimo
- Ciorciaro
- Claas
- Clark
- Clofent-Sanchez
- Close
- Cochran
- Cogen
- Col
- Cole
- Colquhoun
- Colwell
- Comert
- Comp
- Conard
- Conri
- Coon
- Coons
- Cooper
- Copeman
- Corrigan
- Costigan
- Coukell
- Cowan
- Criado
- Cropp
- Cross
- Cross
- Croxatto
- Cullen
- Curtis
- Curtis
- Dahlman
- Dahlman
- Dahlman
- Daly
- Darlington
- Das
- Davies
- Davies
- Davies
- Davis
- Day
- De Denus
- De Leveld
- de Queiroz Fernandes Araujo
- De Swiet
- de Swiet
- de Swiet
- de Teresa
- DeChatelet
- Deliargyris
- Delzell
- Dempfle
- Denbow
- Dent
- Derry
- Dery
- Dery
- Desmond
- Destro
- Deykin
- Deykin
- DiCato
- Dickinson
- Diener
- Diener
- Diener
- Diener
- Diener
- Diener
- DiMarco
- Direct Thrombin Inhibitor Trialists’ Collaborative Group
- Donahue
- Doogue
- Doolan
- Douketis
- Dove
- Dubach
- Dubach
- Dukes
- Duncan
- Dundar
- Dux
- Duxbury
- Dybedal
- Eby
- Eckstein
- Eckstein
- Eden
- Editorial
- Edwards
- Edwards
- Egger
- Eghtesady
- Eichler
- Eichler
- Ekelund
- Eldon
- Elias
- Ellie
- Elliot
- Ellis
- Engel
- Engelsen
- Englberger
- Enquete de prevention secondaire de l'infarctus du Myocarde’ Research Group
- Eriksson
- Eriksson
- Eriksson
- Eriksson
- Eriksson
- Eriksson
- Eriksson
- Eriksson
- Eryonucu
- Eryonucu
- Faaij
- Fager
- Fang
- Fareed
- Farr
- Farver
- Farwell
- Faulkner
- Feder
- Fenyvesi
- Ferguson
- Fiessinger
- Fihn
- Fisher
- Flessa
- Florholmen
- Fondevila
- Food and Drug Administration HHS
- Fored
- Forestier
- Foster
- Fowlie
- Fox
- Francis
- Francis
- Freeland
- Freimark
- Fried
- Friedrich
- Frost
- Gadisseur
- Gago-Dominguez
- Gallus
- Gandolfi
- Garces
- Garcia Rodriguez
- Garrett
- Gayer
- Gelwix
- Gemmill
- Gent
- Gericke
- Gille
- Gilutz
- Ginsberg
- Ginsberg
- Ginsberg
- Ginsberg
- Ginsberg
- Ginsberg
- Ginsberg
- Ginsberg
- Giorgini
- Gitlin
- Godal
- Godley
- Godolphin
- Goldberg
- Golding
- Gore
- Goring
- Gottschlich
- Grabe
- Graham
- Grant
- Grau
- Grau
- Grau
- Gray
- Gray
- Green
- Green
- Greer
- Greer
- Greinacher
- Gretler
- Griffin
- Grimm
- Gruppo Italiano per lo Studio della Streptocochinasi nell'Infarto miocardico (GSSI)
- Guazzi
- Guertin
- Gupta
- Gupta
- Gupta
- Gupta
- Gupta
- Gur
- Gurwitz
- Gustovic
- Gutnik
- Gyllfors
- Habbab
- Habib
- Hacquard
- Haefeli
- Haj
- Haj
- Hall
- Hall
- Hamer
- Handschin
- Hanley
- Hannaford
- Hansen
- Hansen
- Hansson
- Harder
- Hardy
- Harenberg
- Harenberg
- Harenberg
- Harker
- Harrington
- Harris
- Hasegawa
- Hass
- Hauptmann
- Haushofer
- Hayden
- Heffner
- Heimark
- Heinzelmann
- Hellem
- Henderson
- Henderson
- Hennekens
- Hermida
- Herrmann
- Hilgard
- Hilgard
- Hill
- Hillis
- Hirsh
- Hirsh
- Hirsh
- Hoffbrand
- Hoh
- Hohenstein
- Holbrook
- Hollman
- Holmes
- Hoover
- Horlocker
- Horn
- Hottelart
- Houwert-de Jong
- Hrebickova
- Hu
- Huhle
- Hui
- Hursting
- Huynh
- Hwang
- Hylek
- Hylek
- Hylek
- Ibbotson
- Ibáñez
- Ikoma
- Ingels
- Inglis
- Iorio
- Isele
- Ishibashi
- ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
- ISIS-3 (Third International Study of Infarct Survival) Collaborative Group
- Israel
- Iturbe-Alessio
- Izzat
- Izzo
- Jablonska
- Jahnchen
- Jalihal
- Jamal
- James
- Janetzky
- Janetzky
- Jappe
- Jassal
- Jenkins
- Jiang
- Jiang
- Jiang
- Jiang
- Johansson
- Johansson
- Jolliet
- Jolobe
- Jolson
- Jones
- Joseph
- Joyce
- Jung
- Kahl
- Kakkasseril
- Kandrotas
- Kandzari
- Kandzari
- Kanwar
- Kaplan
- Kaplan
- Kates
- Kathiresan
- Keam
- Kelly
- Kelton
- Kennedy
- Keough
- Kereiakes
- Khalid
- Khambekar
- Khaykin
- Kieta
- Kim
- Kim
- Kingham
- Kinshuck
- Klaassen
- Klebanoff
- Kleiman
- Knijff-Dutmer
- Knoell
- Kober
- Koch
- Koch
- Koch
- Koch
- Koch-Weser
- Koch-Weser
- Kolilekas
- Kondo
- Koren-Michowitz
- Kort
- Kowalski
- Krishnan
- Krogstad
- Kruis-de Vries
- Kubitza
- Kukongviriyapan
- Kumar
- Kuo
- Kupfer
- Lacey
- Lacroix
- Laine
- Laizure
- Lam
- Lambert
- Lambert
- Lanas
- Lanas
- Landefeld
- Landefeld
- Landefeld
- Landefeld
- Langford
- Langman
- Lansdorp
- Lassen
- Laster
- Latini
- Lau
- Launbjerg
- Le
- Leaf
- Lear
- Lee
- Lee
- Leizorovicz
- Leizorovicz
- Leizorovicz
- Leizorovicz
- Lenderink
- Leone
- Leone
- Leor
- Leor
- Lesesve
- Lesho
- Lette
- Levesque
- Levine
- Levine
- Levine
- Levine
- Levine
- Levine
- Levy
- Levy
- Lew
- Lewandowski
- Lewis
- Lindgren
- Lione
- Llibre
- Lo
- Lo
- Lodwick
- Loeliger
- Loeliger
- Loftin
- Lohman
- Loke
- Love
- Lowenstein
- Lown
- Lubenow
- Ludin
- Ludwig
- Ludwig
- Ludwig
- Ludwig
- MacDonald
- Macdonald
- MacIntyre
- Maclennan
- Maetzke
- Mager
- Magid
- Magnani
- Mahe
- Mailloux
- Mailloux
- Makino
- Makris
- Malfertheiner
- Malik
- Manfredini
- Mansoor
- Mant
- Manu
- Marbet
- Marder
- Marinella
- Marlar
- Marotel
- Martchenke
- Martel
- Martelli
- Martin
- Martinez Aviles
- Martinez Perez-Balsa
- Martinowitz
- Massel
- Mathiesen
- Matthews
- Matziolis
- Maurer
- Mayer
- Mazzucconi
- McCarthy
- McConnell
- McElnay
- McInnes
- McKenna
- McKinney
- McLaughlin
- McLenachan
- McNulty
- McNulty
- McWhirter
- Meade
- Meeks
- Meinertz
- Meisel
- Meissner
- Meloni
- Mendez
- Mendez
- Meredith
- Merlini
- Meyer
- Mi
- Michot
- Mielants
- Mims
- Mitchell
- Mix
- Moll
- Monig
- Monterrey-RodrĂguez
- Montgomery
- Montserrat
- Moore
- Moore
- Moore
- Mora
- Moreau
- Moreau-Cabarrot
- Morel
- Morkunas
- Mortensen
- Moulton
- Mullins
- Multicentre Acute Stroke Trial—Italy (MAST-I) Group
- Mungall
- Muniesa
- Muszkat
- Nagge
- Nandhagopal
- Nappi
- National Drugs Advisory Board
- Nawarskas
- Necheles
- Nedeljkovic
- Nelson-Piercy
- Nenci
- Neubauer
- Neuhaus
- Nguyen
- Nikolsky
- Noel
- Norman
- Nurden
- Nurmohamed
- Nurmohamed
- Nutescu
- O'Donnell
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'Reilly
- O'toole
- Oakley
- Oates
- Oberg
- Offerhaus
- Ohm
- Ohno
- Ohno
- Oldenburg
- Oliveira
- Ollier
- Olsson
- Olwin
- Omri
- Ong
- Oosterga
- Ordog
- Orme
- Orr
- Ortin
- Oster
- Ottervanger
- Owens
- Oyama
- Paccaly
- Pachter
- Page
- Pan
- Pancioli
- Papamitsakis
- Parker
- Parker
- Passmore
- Passmore
- Patel
- Patel
- Patel
- Pavlou
- Pelletier
- Pelouze
- Pena-Alonso
- Penning-van Beest
- Penninga
- Penot
- Pereira
- Perkins
- Personne
- Petersen
- Petitou
- Petitt
- Peto
- Petrick
- Petroski
- Petty
- Pfeffer
- Pfeifer
- Pharand
- Phillips
- Phillips
- Phillips
- Picano
- Pierce
- Pierce
- Pierzchalska
- Pietschmann
- Pigatto
- Pinton
- Piorkowski
- Piper
- Pleskow
- Plotz
- Polkey
- Poovalingam
- Porter
- Prasad
- Price
- Prince
- Privitera
- Purvis
- Pyerele
- Pyorala
- Queen
- Qureshi
- Qureshi
- Raburn
- Ramanathan
- Ramsay
- Rao
- Rao
- Razakjr
- Rebeiz
- Regazzoni
- Reichert
- Reiter
- Report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council
- Reuben
- Reuter
- Reverter
- Rexrode
- Rezkalla
- Rhodes
- Rice
- Rindone
- Rindone
- Risc
- Ritter
- Riva
- Rivier
- Rizzoni
- Robinson
- Robinson
- Robinson
- Rocci
- Roderick
- Rodrigo Casanova
- Rodwell
- Roe
- Rohr
- Rosado
- Rosenblatt
- Rosenthal
- Routledge
- Routledge
- Rudolf
- Rudolf
- Rumack
- Rymer
- Sabbe
- Sacher
- Sahn
- Sakai
- Salengro
- Sallah
- Sallen
- Sam
- Samama
- Samama
- Samuels
- Sanchez
- Sanders
- Santamaria
- Sarich
- Sarich
- Sarich
- Sarich
- Sarin
- Sarrot-Reynauld
- Sasse
- Sautereau
- Saw
- Schell
- Scher
- Schernhammer
- Schimpf
- Schlag
- Schreiber
- Schulman
- Schulman
- Schulman
- Schwarz
- Schweizer
- Scott
- Scott
- Seaton
- Self
- Self
- Self
- Selker
- Serebruany
- Serlin
- Serlin
- Settipane
- Shapiro
- Sharis
- Sharis
- Sharma
- Sharma
- Shaw
- Shaw
- Shepherd
- Shepherd
- Sherman
- Shields
- Shireman
- Siegel
- Siegman-Igra
- Silberman
- Simoons
- Singh
- Singleton
- Sioris
- Skowasch
- Slone
- Smith
- Smith
- Smith
- Snyder
- Sola Alberich
- Sommer
- Sorber
- Sorensen
- Sperling
- Spiers
- Spigset
- Spigset
- Srinivasan
- Srivastava
- Stafford
- Stafford-Smith
- Stavorovsky
- Steering Committee of the Physicians’ Health Study Research Group
- Steering Committee of the Physicians’ Health Study Research Group
- Stein
- Steinhubl
- Stephens
- Sternberg
- Steurer
- Stevenson
- Stevenson
- Stewart
- Stricker
- Strupp
- StĂĽrzebecher
- Su
- Suazo-Barahona
- Suleiman
- Susano
- Suvarna
- Swine
- Swords
- Szabo
- Szczeklik
- Szczeklik
- Tai
- Taillefer
- Takishita
- Tam
- Tam
- Tam
- Tanaka
- Tang
- Tardy
- Tashima
- Tatarchenko
- Tateishi
- Taylor
- Taylor
- Taylor
- Taylor
- Teepe
- Temes
- Temple
- Teo
- The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators
- The Canadian Cooperative Study Group
- The Dutch TIA Trial Study Group
- The EPIC Investigation
- The EPILOG Investigators
- The EPISTENT Investigators
- The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators
- The Heart Outcomes Prevention Evaluation Investigators
- The International Study Group
- The RISC Group
- The SALT Collaborative Group
- The SOLVD investigators
- The SOLVD investigators
- The Stroke Prevention in Atrial Fibrillation Investigators
- Theis
- Theis
- Thompson
- Thornes
- Thurnheer
- Tiaden
- Tiaden
- Tiaden
- Tiaden
- Tio
- Toll
- Toon
- Toon
- Toon
- Torngren
- Toulemonde
- Tramèr
- Tramèr
- Tran
- Tran
- Trapolin
- Trenk
- Trenque
- Trilli
- Tripi
- Trivier
- Tsai
- Tsang
- Tsutaoka
- Turpie
- Turpie
- Turpie
- Turpie
- Turpie
- Turpie
- Udall
- Udall
- Uzan
- Vaes
- Valdes
- Valdivielso
- van Amstel
- van Dijk
- van Haren
- Van Wijngaarden
- Vanderweidt
- Vaughan
- Verhagen
- Verho
- Verme-Gibboney
- Verstraete
- Verstuyft
- Vesell
- Viaro
- Vincent
- Visser
- Visser
- Visser
- Visser
- Vitale
- Wahlander
- Walenga
- Walenga
- Walker
- Wallentin
- Wallis
- Walter
- Walters
- Walters
- Wang
- Ward
- Warkentin
- Warkentin
- Warkentin
- Warkentin
- Warkentin
- Warkentin
- Warkentin
- Warkentin
- Warkentin
- Wartski
- Watson
- Watson
- Watt
- Watt
- Wattiaux
- Watts
- Wei
- Weidner
- Weil
- Weiler
- Weiner
- Weisman
- Weiss
- Wellesley
- Werblin
- Werler
- White
- Whiting
- Wilcox
- Wilde
- Wilkins
- Wilkins
- Williams
- Williamson
- Woldtvedt
- Wolf
- Wolzt
- Wong
- Wong
- Wood
- Woods
- World Health Organization (WHO)
- Wright
- Wutschert
- Wyld
- Wynn
- Wynne
- Wysowski
- Yamamoto
- Yamamoto
- Yeh
- Yilmaz
- Yosipovitch
- Yu
- Yuan
- Yue
- Zacharski
- Zacharski
- Zauber
- Zeller
- Zhu
- Zimmerman
- Zupancic-Salek
- Publication venue
- 'Elsevier BV'
- Publication date
- 01/01/2009
- Field of study